Overview
Status
Active
Registry date
2003-10-03
Share capital
5,000,000.00 PLN
Registered address
Odrowąża 11, 03-310 Warszawa, Poland
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 96 days for 2021).
- 202530/07/2026
- 202410/07/2025
- 202315/05/2024
- 202229/06/2023
- 202119/10/2022
- 202024/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.14mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 912.07kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 198.30kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 5.48mMedianUSD 608.93kAverageUSD 11.85m
Industry
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Bogdańskiage 70 | 9,995 | $1,349,945.98 | 99.95% |
Others | 5 | $675.31 | 0.05% |
Manner of representation
Each member of the management board independently, or the commercial proxy independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-07-01.
91 1600 1462 1807 9547 2000 0001
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
13 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Mar 2, 2026 | Bankruptcy notice | |
| Jan 15, 2025 | List of claims | |
| Aug 23, 2024 | Bankruptcy notice | |
| Jun 15, 2023 | Trustee auction | |
| Oct 3, 2022 | Bankruptcy notice |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl | ||
| Medmess Kropaczewskisp. k. | $4,516,614.15 | medmess.pl | ||
| Brandexsp. z o.o. | $1,958,619.75 | brandex.pl | ||
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Tricopat Globalsp. z o.o. | $1,772,824.41 | tricopatglobal.com | ||
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | ||
| Dental Solutionssp. z o.o. | $611,683.37 | dentalsolutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-10-26 | Name change ("intra" → "intra" Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2016-02-11 | PKD change (Removed: 21 codes) | |
| 2012-11-14 | PKD change (Removed: 55.21.Z; Added: 52.10.B, 52.21.Z, 52.24.C, 64.92.Z) | |
| 2012-04-23 | PKD change (Added: 7 codes) | |
| 2010-10-18 | Share capital increase (50,000.00 PLN → 5,000,000.00 PLN) |
FAQ
The main business activity of Intra focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 3, 2003.
The headquarters is located at: Odrowąża 11, 03-310 Warszawa.
The share capital of the company is PLN 5,000,000 (approx. $1.4 million).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $1,143,730 in 2025, which is a decrease of 11.1% compared to 2024.
Yes, the company recorded a net profit of $912,066 in 2025, meaning the company increased its profit by 96.4%.
The largest operating cost category falls under external services. This category amounted to $101,110 in 2025, representing 51% of all operating expenses.
Last updated: 2026-07-30